A. 23 human leukemia cell lines were treated with increasing concentrations of ART-838 or AS for 48h, and then cytotoxicity was assessed via fluorescent alamarBlue assay. Following subtraction of background fluorescence from all wells, fluorescence of drug-treated cells was normalized to that of vehicle (<0.5% DMSO)-treated cells to determine the effect of each drug concentration on viability. Each cell line was tested in triplicate and in at least three independent experiments. IC50 (concentration that inhibits cell growth by 50%) values were calculated using CompuSyn software (ComboSyn, Paramus, NJ). All IC50s were determined using cells cultured in RPMI containing 10% FBS. In addition several cell lines were initially cultured and tested in alternative media (Supplementary Table S2). Bisecting lines indicate mean IC50s and error bars, SEM (**, p<.01) B. MOLM14 (AML) or MV-4-11 (biphenotypic leukemia) cells were pretreated with the indicated concentrations of ART-838, AS, or vehicle (0.5% DMSO) for 24h then cultured in semi-solid medium, in triplicate, for 7-10d before colonies were enumerated. Colony counts were normalized to vehicle-treated controls (100%). Three independent experiments were performed.